LIVN
Price
$90.98Alerts
Change
-$0.16 (-0.18%)
Updated
Nov 11 closing price
Capitalization
4.96B
105 days until earnings call
Intraday BUY SELL Signals
OFIX
Price
$7.18Alerts
Change
+$0.06 (+0.84%)
Updated
Nov 11 closing price
Capitalization
320.57M
100 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LIVN vs OFIX

LIVN vs OFIX Comparison Chart in %
View a ticker or compare two or three
VS
LIVN vs. OFIX commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIVN is a Hold and OFIX is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for LIVN with price predictions
Nov 10, 2026

LIVN in -4.46% downward trend, declining for three consecutive days on November 06, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where LIVN declined for three days, in 229 of 309 cases, the price declined further within the following month. The odds of a continued downward trend are 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for LIVN moved out of overbought territory on November 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 16 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 59%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 59 cases where LIVN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 69%.

LIVN broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on LIVN as a result. In 60 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.

The Moving Average Convergence Divergence (MACD) for LIVN just turned positive on October 09, 2026. Looking at past instances where LIVN's MACD turned positive, the stock continued to rise in 28 of 46 cases over the following month. The odds of a continued upward trend are 61%.

LIVN moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for LIVN crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.

Following a +1.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where LIVN advanced for three days, in 206 of 305 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

The Aroon Indicator entered an Uptrend today. In 109 of 186 cases where LIVN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. LIVN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 55 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.741) is normal, around the industry mean (4.142). P/E Ratio (26.084) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.899) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (2.954) is also within normal values, averaging (40.124).

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 79 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 88 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LIVN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

A.I.Advisor
a Summary for OFIX with price predictions
Nov 10, 2026

OFIX sees MACD Histogram just turned negative

OFIX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 02, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 53 instances where the indicator turned negative. In 46 of the 53 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OFIX as a result. In 71 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.

OFIX moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for OFIX crossed bearishly below the 50-day moving average on November 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 18 of 23 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 78%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OFIX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for OFIX's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +11.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where OFIX advanced for three days, in 202 of 285 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.

OFIX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 112 of 149 cases where OFIX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. OFIX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.747) is normal, around the industry mean (4.142). P/E Ratio (-5.178) is within average values for comparable stocks, (3.291). OFIX's Projected Growth (PEG Ratio) (48.825) is slightly higher than the industry average of (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.431) is also within normal values, averaging (40.124).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OFIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
LIVN vs OFIX: Fundamental Ratings
LIVN
OFIX
OUTLOOK RATING
1..100
8713
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
98
Overvalued
PROFIT vs RISK RATING
1..100
88100
SMR RATING
1..100
5594
PRICE GROWTH RATING
1..100
3679
P/E GROWTH RATING
1..100
7914
SEASONALITY SCORE
1..100
7575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LIVN's Valuation (75) in the Medical Specialties industry is in the same range as OFIX (98). This means that LIVN’s stock grew similarly to OFIX’s over the last 12 months.

LIVN's Profit vs Risk Rating (88) in the Medical Specialties industry is in the same range as OFIX (100). This means that LIVN’s stock grew similarly to OFIX’s over the last 12 months.

LIVN's SMR Rating (55) in the Medical Specialties industry is somewhat better than the same rating for OFIX (94). This means that LIVN’s stock grew somewhat faster than OFIX’s over the last 12 months.

LIVN's Price Growth Rating (36) in the Medical Specialties industry is somewhat better than the same rating for OFIX (79). This means that LIVN’s stock grew somewhat faster than OFIX’s over the last 12 months.

OFIX's P/E Growth Rating (14) in the Medical Specialties industry is somewhat better than the same rating for LIVN (79). This means that OFIX’s stock grew somewhat faster than LIVN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LIVNOFIX
RSI
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 14 days ago
68%
Bullish Trend 8 days ago
71%
Declines
ODDS (%)
Bearish Trend 6 days ago
74%
Bearish Trend 6 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
75%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (LIVN: $91.14 vs. OFIX: $7.12)
Brand notoriety: LIVN and OFIX are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: LIVN: 103% vs. OFIX: 167%
Market capitalization -- LIVN: $4.96B vs. OFIX: $320.57M
LIVN [@Medical/Nursing Services] is valued at $4.96B. OFIX’s [@Medical/Nursing Services] market capitalization is $320.57M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LIVN’s FA Score shows that 0 FA rating(s) are green while OFIX’s FA Score has 1 green FA rating(s).

  • LIVN’s FA Score: 0 green, 5 red.
  • OFIX’s FA Score: 1 green, 4 red.
According to our system of comparison, LIVN is a better buy in the long-term than OFIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LIVN’s TA Score shows that 6 TA indicator(s) are bullish while OFIX’s TA Score has 5 bullish TA indicator(s).

  • LIVN’s TA Score: 6 bullish, 4 bearish.
  • OFIX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, LIVN is a better buy in the short-term than OFIX.

Price Growth

LIVN (@Medical/Nursing Services) experienced а +14.07% price change this week, while OFIX (@Medical/Nursing Services) price change was -18.72% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.76%. For the same industry, the average monthly price growth was -4.66%, and the average quarterly price growth was -1.83%.

Reported Earning Dates

LIVN is expected to report earnings on Feb 24, 2027.

OFIX is expected to report earnings on Feb 19, 2027.

Industries' Descriptions

@Medical/Nursing Services (-2.76% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

LIVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIVN has been loosely correlated with CRL. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LIVN jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIVN
1D Price
Change %
LIVN100%
-1.59%
CRL - LIVN
48%
Loosely correlated
-2.13%
UFPT - LIVN
45%
Loosely correlated
-1.51%
PHG - LIVN
44%
Loosely correlated
-1.23%
OFIX - LIVN
43%
Loosely correlated
-9.87%
STE - LIVN
43%
Loosely correlated
+0.07%
More

OFIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, OFIX has been loosely correlated with SYK. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if OFIX jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OFIX
1D Price
Change %
OFIX100%
-9.87%
SYK - OFIX
50%
Loosely correlated
-0.44%
ENOV - OFIX
48%
Loosely correlated
-1.12%
ATEC - OFIX
47%
Loosely correlated
-5.15%
PODD - OFIX
46%
Loosely correlated
-1.17%
MMSI - OFIX
46%
Loosely correlated
-0.69%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VOE211.20N/A
N/A
Vanguard Morningstar Mid-Cap Value ETF (VOE)
RNIN38.19-0.01
-0.03%
Bushido Capital US SMID Cap Equity ETF (RNIN)
JULJ24.86-0.04
-0.18%
Innovator Premium Income 30 Barrier ETF - July (JULJ)
LQDI25.01-0.21
-0.83%
iShares Inflation Hedged Corporate Bond ETF (LQDI)
AIS53.31-0.82
-1.51%
VistaShares Artificial Intelligence Supercycle ETF